Aprea Therapeutics Inc. (APRE)
Aprea Therapeutics Statistics
Share Statistics
Aprea Therapeutics has 5.53M shares outstanding. The number of shares has increased by 1.14% in one year.
| 5.53M |
| 1.14% |
| 1.05% |
| 37.7% |
| 4.83M |
| 753 |
| 2.75% |
Short Selling Information
The latest short interest is 73.65K, so 1.33% of the outstanding shares have been sold short.
| 73.65K |
| 1.33% |
| 1.51% |
| 2.1 |
Valuation Ratios
The PE ratio is -1.4 and the forward PE ratio is -1.32. Aprea Therapeutics's PEG ratio is 0.03.
| -1.4 |
| -1.32 |
| 12.06 |
| 0.1 |
| 0.94 |
| -1.34 |
| 0.03 |
Enterprise Valuation
Currently the Enterprise Value (EV) is not available for Aprea Therapeutics.
| n/a |
| n/a |
| n/a |
| n/a |
Financial Position
The company has a current ratio of 7.01, with a Debt / Equity ratio of 0.
| 7.01 |
| 7.01 |
| 0 |
| n/a |
| n/a |
| 0 |
Financial Efficiency
Return on Equity is n/a and Return on Invested Capital is n/a.
| n/a |
| n/a |
| n/a |
| $187,822.62 |
| $-1,619,838.88 |
| 8 |
| 0.06 |
| n/a |
Taxes
| n/a |
| 0% |
Stock Price Statistics
The stock price has increased by -56.92% in the last 52 weeks. The beta is 1.61, so Aprea Therapeutics's price volatility has been higher than the market average.
| 1.61 |
| -56.92% |
| 1.7 |
| 2.83 |
| 52.86 |
| 27,390 |
Income Statement
In the last 12 months, Aprea Therapeutics had revenue of 1.5M and earned -12.96M in profits. Earnings per share was -2.35.
| 1.5M |
| 1.48M |
| -14.32M |
| -12.96M |
| -12.94M |
| -12.96M |
| -2.35 |
Balance Sheet
The company has 22.85M in cash and 0 in debt, giving a net cash position of 22.85M.
| 22.85M |
| n/a |
| n/a |
| -321.04M |
| 20.22M |
| 16.47M |
Cash Flow
In the last 12 months, operating cash flow was -13.56M and capital expenditures -15.48K, giving a free cash flow of -13.57M.
| -13.56M |
| -15.48K |
| -13.57M |
| -2.46 |
Margins
Gross margin is 98.51%, with operating and profit margins of -953% and -862.43%.
| 98.51% |
| -953% |
| -862.43% |
| -862.43% |
| -860.94% |
| -953% |
| -903.26% |
Dividends & Yields
APRE does not appear to pay any dividends at this time.
| n/a |
| n/a |
| n/a |
| n/a |
| n/a |
| n/a |
Analyst Forecast
The average price target for APRE is $15.5, which is 715.8% higher than the current price. The consensus rating is "Buy".
| $15.5 |
| 715.8% |
| Buy |
| 2 |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| n/a |
| n/a |
| n/a |
| n/a |
Stock Splits
The last stock split was on Feb 13, 2023. It was a backward split with a ratio of 1:20.
| Feb 13, 2023 |
| backward |
| 1:20 |
Scores
| -22.74 |
| 1 |